Mark Parry has worked with Intertek for over 20 years since graduating from Cambridge University (UK) and currently works as the Senior Scientific Director, supporting the wide range of analytical, formulation, product development and research activities across the company. Mr Parry has worked in a range of pharmaceutical analysis and formulation development areas, with a particular focus on inhaled and nasal drug products. Mostly working in the pre-approval stages, Mr Parry’s background includes extensive experience with product and formulation development, as well as method development and validation, stability studies and pharmaceutical development activities for a wide range of clients across the pharmaceutical industry.

More contributions